Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab
- PMID: 17143963
- PMCID: PMC4087505
- DOI: 10.3748/wjg.v12.i45.7391
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab
Abstract
Rituximab has been associated with the development of cytomegalovirus enterocolitis in immunosuppressed patients. A 51-year-old patient with diffuse large B-cell lymphoma who received a conditioning chemotherapy regimen (RCVP and RICE) consisting of rituximab before bone marrow transplantation went on to develop cytomegalovirus enterocolitis. This supports evidence from previously described cases that rituximab may be associated with cytomegalovirus enterocolitis.
Comment on
-
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.World J Gastroenterol. 2006 Mar 28;12(12):1978-9. doi: 10.3748/wjg.v12.i12.1978. World J Gastroenterol. 2006. PMID: 16610013 Free PMC article. No abstract available.
Similar articles
-
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.Leuk Lymphoma. 2007 Feb;48(2):431-3. doi: 10.1080/10428190601059704. Leuk Lymphoma. 2007. PMID: 17325912 No abstract available.
-
Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.Int J Hematol. 2007 Apr;85(3):264-6. doi: 10.1532/IJH97.06197. Int J Hematol. 2007. PMID: 17483065
-
Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.Int J Hematol. 2005 Nov;82(4):312-4. doi: 10.1532/IJH97.NA0504. Int J Hematol. 2005. PMID: 16298821
-
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Semin Oncol. 2002. PMID: 11842390 Review.
-
Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.J Clin Oncol. 2002 Aug 15;20(16):3545-57. doi: 10.1200/JCO.2002.02.126. J Clin Oncol. 2002. PMID: 12177115 Review. No abstract available.
References
-
- Czuczman MS, Grillo-López AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol. 1999;17:268–276. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources